生物标志物能否推动抗逆转录病毒治疗时代的HIV研究与照护?
尽管HIV-1 RNA被抑制到检测限以下且多数CD4+ T细胞计数改善, aging with HIV人群仍存在慢性炎症、高凝状态和免疫功能障碍。与慢性炎症相关的生物标志物也与HIV相关非AIDS事件(心血管病、多种癌症、肝病、肾病、神经认知下降和骨质疏松)相关。作者提出生物标志物的操作性定义,并探讨其如何促进从治疗发现到干预试验和临床管理的转化路径。
要点
- HIV感染者即使病毒抑制仍存在慢性炎症、高凝和免疫功能障碍。
- 慢性炎症相关生物标志物与多种HIV相关非AIDS事件相关。
- 未来可能需要多标志物或加权指数指导发现和治疗。
核心结论
- 生物标志物可能推动HIV从治疗发现到干预试验和临床管理的转化进程。
研究设计与样本
- 由临床试验者、流行病学家、实用性试验者和转化科学家共同提出的概念性论述,未报告系统检索或样本量。
主要发现
- HIV-1 RNA抑制且CD4+ T细胞改善后,与人口学和行为学相似未感染者相比,HIV感染者仍存在过度低水平炎症、高凝状态和免疫功能障碍。
- 与慢性炎症相关的多种生物标志物也与HIV相关非AIDS定义事件相关,包括心血管病、多种癌症、肝病、肾病、神经认知下降和骨质疏松。
- 慢性HIV感染可能与长期治疗毒性和ART启动后体重增加存在交互作用。
临床怎么用
- 未来生物标志物指导的发现和治疗可能需要关注多个生物标志物,并可能采用加权指数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite achieving human immunodeficiency virus type 1 (HIV-1) RNA suppression below levels of detection and, for most, improved CD4+ T-cell counts, those aging with HIV experience excess low-level inflammation, hypercoagulability, and immune dysfunction (chronic inflammation), compared with demographically and behaviorally similar uninfected individuals. A host of biomarkers that are linked to chronic inflammation are also associated with HIV-associated non-AIDS-defining events, including cardiovascular disease, many forms of cancer, liver disease, renal disease, neurocognitive decline, and osteoporosis. Furthermore, chronic HIV infection may interact with long-term treatment toxicity and weight gain after ART initiation. These observations suggest that future biomarker-guided discovery and treatment may require attention to multiple biomarkers and, possibly, weighted indices. We are clinical trialists, epidemiologists, pragmatic trialists, and translational scientists. Together, we offer an operational definition of a biomarker and consider how biomarkers might facilitate progress along the translational pathway from therapeutic discovery to intervention trials and clinical management among people aging with or without HIV infection.
引用
- Justice AC, Erlandson KM, Hunt PW, et al. Can Biomarkers Advance HIV Research and Care in the Antiretroviral Therapy Era? J Infect Dis. 2018. PMID: 29165684. doi:10.1093/infdis/jix586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。